Skip to main content
SGC
NASDAQ Manufacturing

SGC Q3: Sales Up 5% to $146M, But Healthcare Apparel Swings to Negative EBITDA

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Apparel Stocks · Consumer
Sentiment info
Negative
Importance info
7
Price
$13.44
Mkt Cap
$214.303M
52W Low
$8.3
52W High
$14.59
52W Position info
62% above low
Off High info
7.9% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

SGC sits 62% above its 52-week low of $8.3.

Summary

SGC's Q3 sales rose 5.4% to $146.0 million with EPS of $0.17, but Healthcare Apparel swung to negative segment EBITDA on $4.0 million of inventory write-downs and customer credit losses. Debt paydown and $30.7 million of nine-month operating cash flow offset the segment weakness.


Key Events · Earnings and Guidance · SGC

  • Q3 Sales Up 5.4%, EPS Down a Penny

    Net sales were $145,994 thousand versus $138,467 thousand a year ago; net income fell to $2,571 thousand from $2,744 thousand, and diluted EPS slipped to $0.17 from $0.18.

  • Healthcare Apparel Swings to Negative EBITDA

    Segment Adjusted EBITDA was -$501 thousand versus +$3,179 thousand a year ago, driven by $4.0 million of incremental inventory write-downs and credit loss charges from a customer's changed financial position.

  • Branded Products Carries the Quarter

    Branded Products segment Adjusted EBITDA rose to $9,843 thousand from $7,524 thousand on 8.2% sales growth, but consolidated Adjusted EBITDA still fell 11.0% to $6,707 thousand.

  • Debt Cut to $78.0 Million

    Total debt fell to $78,037 thousand from $93,656 thousand at December 31, 2025 after the August 7, 2026 refinancing into facilities maturing August 2031; cash was $27,924 thousand and the company was in compliance with its 1.25x fixed charge and 4.00x net leverage covenants.


Analysis · SGC · Manufacturing

The headline numbers look steady — sales rose 5.4% to $146.0 million and net income was $2.57 million ($0.17 per diluted share) — but the segment detail reveals where the strain lies. Healthcare Apparel's Adjusted EBITDA flipped to -$0.5 million from +$3.2 million a year ago, dragged down by $4.0 million of incremental inventory write-downs in the quarter and credit loss charges after a customer's financial position deteriorated. Branded Products carried the quarter with segment Adjusted EBITDA of $9.8 million, up from $7.5 million. Consolidated Adjusted EBITDA still fell 11% to $6.7 million. The balance sheet provides the offset: debt is down to $78.0 million from $93.7 million at year-end after the August refinancing, cash stands at $27.9 million, and nine-month operating cash flow was $30.7 million versus $1.3 million a year ago. The risk to watch is the CID Resources trade name — the annual test passed with only a 2-4% fair-value cushion, so another leg down in Healthcare Apparel projections could force a second impairment after the $2.6 million charge already taken in Q2.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SGC was trading at $13.44 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $214.3M. The 52-week trading range was $8.30 to $14.59. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SGC - Latest Insights

SGC
Nov 09, 2026, 7:05 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $13.44
Real-time Price: $13.44 info
Change: $0 (0%) info
Market Cap: $214.303M info
SGC
Nov 02, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.29
Real-time Price: $13.44 info
Change: +$1.15 (+9%) info
Market Cap: $214.303M info
SGC
Aug 04, 2026, 8:05 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $13.50
Real-time Price: $13.44 info
Change: -$0.060 (-0.44%) info
Market Cap: $214.303M info
SGC
Aug 04, 2026, 7:27 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $13.50
Real-time Price: $13.44 info
Change: -$0.060 (-0.44%) info
Market Cap: $214.303M info
SGC
Jul 07, 2026, 4:39 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $13.01
Real-time Price: $13.44 info
Change: +$0.430 (+3%) info
Market Cap: $214.303M info